Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1986-05-05
1990-02-20
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 88, 530350, A61K 3902, A61K 3909, A61K 39102, C07K 1504
Patent
active
049025066
ABSTRACT:
An immunogenic conjugate which is the reductive amination product of an immunogenic capsular polymer fragment having at least one reducing group and derived from a bacterial capsular polymer of a bacterial pathogen, and a bacterial toxin or toxoid. The invention also relates to methods for the preparation of the conjugates, a vaccine containing the conjugates which elicits effective levels of anti-capsular polymer antibodies in humans. Also disclosed are methods for inducing active immunization against systemic infection in young mammals caused by bacterial pathogens comprising the administration of an immunogenic amount of the above-described conjugate. In a preferred embodiment, the capsular polymer fragment prior to conjugation has at least one aldehyde group at each end of the fragment. The final conjugate made with such capsular polymers has a lattice or network structure, and provides extremely high levels of anti-capsular polymer antibodies in infants.
REFERENCES:
patent: 4196192 (1980-04-01), Kuo
patent: 4210641 (1980-07-01), Brossard et al.
patent: 4220717 (1980-09-01), Kuo
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4411888 (1983-10-01), Klipstein et al.
patent: 4451446 (1984-05-01), Vandevelde et al.
patent: 4459286 (1984-07-01), Hilleman et al.
patent: 4496538 (1985-01-01), Gordon
Geyer et al., Med. Microbiol. Immunol. 165:271 (1979).
Schneerson et al., J. Exptl. Med. 152:361 (1980).
Schwartz et al., Arch. Biochem. Biophys. 181:542 (1977).
Schneerson et al., New Developments with Human and Veterinary Vaccines, Alan R. Liss, Inc., New York, pp. 77-94 (1980).
Stein et al., J. Immunol. 128(3): 1350-1354 (1982).
Galanos et al., European J. Biochem. 8: 332-36 (1969).
Zamenhof et al., J. Biol. Chem. 208: 695-704 (1953).
Beuvery et al., Infec. Immun. 37(1): 15-22 (1982).
Lin et al., Immunol. 46: 333-42 (1982).
Schneersen et al., Progress in Allergy, Karger, Basel, vol. 33, pp. 144-158 (1983).
Anderson, Infect. Immun. 39(1): 233-38 (1983).
Tsay et al., Abstract 3348, Federation Proceedings, vol. 42, No. 4 (Mar. 5, 1983).
Tsay et al., Abstract 217, Federation Proceedings, Abstract 43:1453 (1984).
Tsay et al., Infect. Immun. 45(1): 217 (1984).
Chu et al., Infect. Immun. 40(1): 245-56 (1983).
Ovary et al., Proc. Soc. Exp. Biol. Med. 114: 72-76 (1963).
Jennings et al., J. Immunol. 127: 1011-1018 (1981).
Uchida et al., Science 115: 901-903 (1972).
Anderson Porter W.
Eby Ronald J.
Hazel Blondel
The University of Rochester
LandOfFree
Immunogenic conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1615261